RADNOR, Pa., May 29, 2024 Certara, Inc. , a global leader in biosimulation, today announced that Company management will participate in the Jefferies Global Healthcare Conference. Company.
Edmond DE Rothschild Holding S.A. lifted its holdings in Certara, Inc. (NASDAQ:CERT – Free Report) by 93.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 769,300 shares of the company’s stock after purchasing an additional 370,820 shares during the quarter. Edmond DE Rothschild […]
Certara, Inc. (NASDAQ:CERT – Get Free Report) has been assigned a consensus rating of “Hold” from the eleven research firms that are currently covering the company, MarketBeat.com reports. Seven investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year target price among […]
Shares of Certara, Inc. (NASDAQ:CERT – Get Free Report) have earned a consensus rating of “Hold” from the eleven brokerages that are presently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year target price among […]
RADNOR, Pa., May 21, 2024 Certara, Inc. , a global leader in model-informed drug development, has appointed Rona Anhalt as Chief Human Resources Officer and Daniel Corcoran as General Counsel. .